<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01305642</url>
  </required_header>
  <id_info>
    <org_study_id>201101IFOPILOT</org_study_id>
    <nct_id>NCT01305642</nct_id>
  </id_info>
  <brief_title>Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study</brief_title>
  <acronym>IFO Pilot</acronym>
  <official_title>Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To analyze the weight gain of very low birth weight infants during a minimum period of three
      weeks before 36 weeks postmenstrual age when infants are fed with breast milk that has been
      individually fortified.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>growth</measure>
    <time_frame>from inclusion at postmentrual age &lt;32 weeks until 36 weeks</time_frame>
    <description>weight gain will be accessed three times per week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>enteral energy intake</measure>
    <time_frame>from inclusion at postmentrual age &lt;32 weeks until 36 weeks</time_frame>
    <description>caloric intake by enteral feeding will be assesed daily</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>growth, tolerance, morbidity</measure>
    <time_frame>from inclusion at postmentrual age &lt;32 weeks until 36 weeks</time_frame>
    <description>gains in length and head circumference will be assessed weekly, tolerance and morbidity throughout study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Postnatal Growth Disorder</condition>
  <arm_group>
    <arm_group_label>Individualized fortification of breast milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Individualized fortification of breast milk</intervention_name>
    <description>Lactose, fat and protein content will be measured prior to breast milk fortification.
Subsequently, breast milk for preterm infants will individually fortified adjusted by using data from milk analysis.</description>
    <arm_group_label>Individualized fortification of breast milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth weight ≤ 1500g and gestational age &lt; 32weeks

          -  Tolerating an enteral intake of ≥ 100 ml/kg/d for ≥ 24h

        Exclusion Criteria:

          -  Infants fed more than 25% of mean caloric intake for a consecutive week with formula
             milk

          -  gastrointestinal malformation, major congenital anomalies and chromosomal
             abnormalities

          -  Babies with enterostoma or short gut syndrome

          -  Fluid restriction below

          -  Renal disease

          -  Sepsis

          -  Necrotizing enterocolitis

          -  Hepatic dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Fusch, MD,PhD,FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster Children's Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Fusch G, Choi A, Rochow N, Fusch C. Quantification of lactose content in human and cow's milk using UPLC-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3759-62. doi: 10.1016/j.jchromb.2011.09.053. Epub 2011 Oct 6.</citation>
    <PMID>22041090</PMID>
  </reference>
  <reference>
    <citation>Fusch G, Rochow N, Choi A, Fusch S, Poeschl S, Ubah AO, Lee SY, Raja P, Fusch C. Rapid measurement of macronutrients in breast milk: How reliable are infrared milk analyzers? Clin Nutr. 2015 Jun;34(3):465-76. doi: 10.1016/j.clnu.2014.05.005. Epub 2014 May 17.</citation>
    <PMID>24912866</PMID>
  </reference>
  <reference>
    <citation>Fusch G, Mitra S, Rochow N, Fusch C. Target fortification of breast milk: levels of fat, protein or lactose are not related. Acta Paediatr. 2015 Jan;104(1):38-42. doi: 10.1111/apa.12804. Epub 2014 Oct 2.</citation>
    <PMID>25213193</PMID>
  </reference>
  <reference>
    <citation>Rochow N, Landau-Crangle E, Fusch C. Challenges in breast milk fortification for preterm infants. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):276-84. doi: 10.1097/MCO.0000000000000167. Review.</citation>
    <PMID>25807355</PMID>
  </reference>
  <reference>
    <citation>Rochow N, Fusch G, Zapanta B, Ali A, Barui S, Fusch C. Target fortification of breast milk: how often should milk analysis be done? Nutrients. 2015 Apr 1;7(4):2297-310. doi: 10.3390/nu7042297.</citation>
    <PMID>25835073</PMID>
  </reference>
  <reference>
    <citation>Fusch G, Kwan C, Huang RC, Rochow N, Fusch C. Need of quality control programme when using near-infrared human milk analyzers. Acta Paediatr. 2016 Mar;105(3):324-5. doi: 10.1111/apa.13305. Epub 2016 Jan 19.</citation>
    <PMID>26663457</PMID>
  </reference>
  <reference>
    <citation>Choi A, Fusch G, Rochow N, Fusch C. Target Fortification of Breast Milk: Predicting the Final Osmolality of the Feeds. PLoS One. 2016 Feb 10;11(2):e0148941. doi: 10.1371/journal.pone.0148941. eCollection 2016.</citation>
    <PMID>26863130</PMID>
  </reference>
  <reference>
    <citation>Kotrri G, Fusch G, Kwan C, Choi D, Choi A, Al Kafi N, Rochow N, Fusch C. Validation of Correction Algorithms for Near-IR Analysis of Human Milk in an Independent Sample Set-Effect of Pasteurization. Nutrients. 2016 Feb 26;8(3):119. doi: 10.3390/nu8030119.</citation>
    <PMID>26927169</PMID>
  </reference>
  <results_reference>
    <citation>Rochow N, Fusch G, Choi A, Chessell L, Elliott L, McDonald K, Kuiper E, Purcha M, Turner S, Chan E, Xia MY, Fusch C. Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants. J Pediatr. 2013 Oct;163(4):1001-7. doi: 10.1016/j.jpeds.2013.04.052. Epub 2013 Jun 12.</citation>
    <PMID>23769498</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2011</study_first_submitted>
  <study_first_submitted_qc>February 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2011</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McMaster Children's Hospital</investigator_affiliation>
    <investigator_full_name>Christoph Fusch</investigator_full_name>
    <investigator_title>Professor and Division Head</investigator_title>
  </responsible_party>
  <keyword>Postnatal development</keyword>
  <keyword>Breast milk fortification</keyword>
  <keyword>Composition of breast milk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Growth Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

